Kyle Champagne, a PhD candidate in biomedical engineering, is developing strains of therapeutic bacteria to detect tumours. His research opens the door to more efficient cancer treatments.
Kyle Champagne, a PhD candidate in biomedical engineering, is developing strains of therapeutic bacteria to detect tumours. His research opens the door to more efficient cancer treatments.
July 2, 2026